ELOXX PHARMACEUTICALS INC (ELOX) Institutional Ownership and Insiders Activity
ELOXX PHARMACEUTICALS INC (ELOX) is widely held by institutional investors, with 22 firms reporting positions valued at approximately $34.70M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Aberdeen Group Plc is the largest disclosed holder, reporting approximately $5.55M in ELOX holdings in its latest filing.
Institutional Holders
22
Total Reported Value
$34.70M
Largest Holder
Aberdeen Group Plc
Largest Position
$5.55M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
22
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
- Aberdeen Group Plc$5.55M
- Ecor1 Capital, Llc$5.55M
- Nantahala Capital Management, Llc$5.55M
- Samsara Biocapital, Llc$5.55M
- Siren, L.L.C.$5.55M
Related ELOX Institutional Insights:
- ELOX 13F Institutional Holders
- ELOX Superinvestors
- ELOX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ELOX Insider Trading & SEC Form 4 Activity
- ELOX Articles
- Top Institutional Investor Stock Rankings